INVA8001 Publication

INVA8001, a Novel and Highly Selective Chymase Inhibitor, Ameliorates Liver Inflammation, Fibrosis, and Hyperplasia in Mdr2 Knockout Mice / Nov, 2025/https://www.biorxiv.org/content/10.1101/2025.11.18.688305v1.full.pdf

Decoding the Mechanisms that Drive Chronic Inflammation to Develop Medicines for Immune-Mediated Inflammatory Disorders

2614 Boston Post Road, Suite #33AR
Guilford, CT 06437, USA

Decoding the Mechanisms that Drive Chronic Inflammation to Develop Medicines for Immune-Mediated Inflammatory Disorders

2614 Boston Post Road Suite #33AR
Guilford, CT 06437, USA